Vornado Realty Trust posted a solid Q2 beat on August 3, jumping 3.9% on the day, yet the stock enters the post-earnings period with the Street still more sceptical than the price action implies.
The earnings reaction was the cleanest signal of the week. VNO gained 3.9% on the day of the release — and is up 2.1% on the week to $40.91 — continuing a recovery that has added more than 20% year-to-date. The next scheduled event is not until November 2, which means the next several weeks are about digesting the print rather than positioning for a catalyst.
What makes the setup interesting is that the stock has now moved above the consensus mean price target of $39.46. Analyst activity around the print has been mixed rather than uniformly bullish. On the positive side, Piper Sandler lifted its neutral target to $44 and Evercore ISI nudged its Outperform target to $46 — both within the last 24 hours. But Morgan Stanley's July 22 downgrade to Underweight, with a $32 target, still stands. Barclays maintains Underweight with a $34 target. The bull case rests on leasing momentum in the Penn District and the potential for buybacks and JV partnerships to crystallise value in the New York City portfolio. Bears remain focused on the capital intensity of PENN 15, which still needs anchor tenants, and unresolved leasing economics at 350 Park Avenue. With two sell-rated firms anchoring the cautious end and a stock now trading above consensus, the Street's aggregate arithmetic has become a mild headwind rather than a tailwind.
Short sellers are retreating, not pressing. Short interest has fallen roughly 9.4% over the past month to about 10 million shares, or 5.2% of the free float — a meaningful level but one moving in the wrong direction for bears. The borrow market is entirely unthreatening: cost to borrow has dropped more than 21% on the week to just 0.33%, and availability is running near 775% — meaning the lending pool has roughly seven times more shares available than are currently shorted. There is no squeeze pressure here, and the relaxed borrow conditions suggest short sellers who want to build new positions face no friction in doing so. Options positioning reinforces the relaxed mood: the put/call ratio of 0.28 is fractionally below its 20-day average of 0.29, essentially neutral, well off its 52-week high of 1.32 that was seen earlier in the year.
Institutional ownership adds a subtle counterpoint worth noting. BlackRock added 1.1 million shares through June 30, bringing its stake to 12.1% of shares. Putnam added 704,000 shares in the same period. These are meaningful increments for the largest holders. On the insider side, Independent Trustee Daniel Tisch spent roughly $5.6 million buying 210,000 shares between late February and mid-March — purchases made at prices in the $25–$28 range, well below the current level. Former president Michael Fascitelli sold 133,000 shares at around $36–$37 in June, capturing some of that gain. The net insider flow of the past 90 days is modestly positive in share terms, though the Fascitelli sale was the larger single transaction by value.
The ORTEX short score has eased to 49.2 from a recent peak above 51, consistent with the month-long decline in short interest. EPS momentum factor scores are exceptionally strong — ranking in the 99th percentile on both 30-day and 90-day measures — which helps explain why bulls are willing to look past a stock that has already moved well past some targets. Among close office REIT peers, SLG led the week with a 5.2% gain, broadly in line with VNO's performance. BXP was quieter, up just 1%. HIW and CUZ both gave ground, down roughly 2% and 2.5% respectively, suggesting VNO and SLG were the specific beneficiaries of post-earnings relief buying in the New York-heavy end of the sector.
With the stock now trading above the Street's mean target and no near-term catalyst until November, the focus shifts to whether leasing updates or any PENN 15 announcement can give bulls fresh ammunition — or whether the post-earnings gap higher quietly fades toward the cluster of neutral targets in the low-to-mid $40s.
See the live data behind this article on ORTEX.
Open VNO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
